VYNE Therapeutics (VYNE)
(Delayed Data from NSDQ)
$1.90 USD
+0.04 (2.15%)
Updated Sep 19, 2024 03:59 PM ET
After-Market: $1.89 -0.01 (-0.53%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.24 |
EPS Last Quarter | -0.22 |
Last EPS Surprise | -15.79% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.86 |
Next Year | -0.87 |
EPS (TTM) | -2.42 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.11M | 0.20M | 0.60M | NA |
# of Estimates | 1 | 1 | 1 | NA |
High Estimate | 0.11M | 0.20M | 0.60M | NA |
Low Estimate | 0.11M | 0.20M | 0.60M | NA |
Year ago Sales | 0.11M | 0.08M | 0.42M | 0.60M |
Year over Year Growth Est. | 0.00% | 150.00% | 41.51% | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.24 | -0.26 | -0.86 | -0.87 |
# of Estimates | 2 | 2 | 2 | 1 |
Most Recent Consensus | -0.24 | -0.26 | -0.86 | -0.87 |
High Estimate | -0.21 | -0.23 | -0.81 | -0.87 |
Low Estimate | -0.26 | -0.28 | -0.91 | -0.87 |
Year ago EPS | -1.85 | -0.20 | -2.72 | -0.86 |
Year over Year Growth Est. | 87.03% | -30.00% | 68.38% | -1.16% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.24 | -0.26 | -0.86 | -0.87 |
7 Days Ago | -0.24 | -0.26 | -0.86 | -0.87 |
30 Days Ago | -0.24 | -0.26 | -0.86 | -0.87 |
60 Days Ago | -0.21 | -0.23 | -0.77 | -0.79 |
90 Days Ago | -0.21 | -0.23 | -0.77 | -0.79 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.24 | -0.26 | -0.86 | -0.87 |
Zacks Consensus Estimate | -0.24 | -0.26 | -0.86 | -0.87 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.22 | -0.15 | -0.20 | -1.85 | NA |
Estimate | -0.19 | -0.24 | -0.50 | -0.76 | NA |
Difference | -0.03 | 0.09 | 0.30 | -1.09 | -0.18 |
Surprise | -15.79% | 37.50% | 60.00% | -143.42% | -15.43% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more